서비스분야
현재 위치:홈 > Services & Solutions > Integrated Projects
Integrated Projects
Medicilon also offers other services including but not limited to evaluation of compound medicines, chemical drugs, biological drug development and IND filing.
Cardiovascular and cerebrovascular diseases generally refer to ischemic or hemorrhagic diseases of the heart, brain and systemic tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, and hypertension.
Medicilon nucleic acid drug R&D platform is an integrated and comprehensive solution that covers drug discovery, CMC and preclinical research services. Based on a rigorous scientific attitude, an open-minded scientific spirit and advanced equipment, our integrated solution can meet the industry's research and development needs for cutting-edge innovative nucleic acid drugs, and undertake research programs like nucleic acid drug discovery, screening and preclinical research services for pharmaceutical companies and scientific research institutions.
Medicilon One-Stop Pharmaceutical Research CDMO is an integrated platform that integrates "APIs + Preparations", and is committed to the technological innovation optimization and commercialization of global pharmaceutical processes, from product development, quality research, quality control, production and declaration to help the new drug research and development in saving time and cost for enterprises.
The solid screening platform of Medicilon process department strictly complies with the registration regulations and regulatory requirements of China NMPA, FDA and other regulatory authorities, studies and controls the solid morphology of drug molecules in API and preparations, and can formulate the optimal screening strategy according to the material characteristics, including but not limited to crystallization method, solvent selection and ion selection.